Month: April 2017

Written by healtheconbotwp

Reforms and physicians’ status in Turkey: Distribution of OOP Health Expenditures for Physicians and Hospitals

from Health Economics at http://bit.ly/2pjEn1z on April 30, 2017 at 08:26AM Turkish health care reforms brought about significant changes regarding the way physicians practice. Dual-time practice, which was very common among public hospital physicians, was gradually banned. While public insurance coverage has been extended to private hospitals, private practices have been left out. The resulting […]

Written by healtheconbotwp

Water Improvement and Health: Historical Evidence on the Effect of Filtering Water on Urban Mortality

from Health Economics at http://bit.ly/2oY8Yz0 on April 30, 2017 at 08:26AM In this paper, I analyse how technologies for cleaning and distributing water can affect health using new historical data from Sweden. The city of Stockholm introduced a slow filter water cleaning system and piped distribu- tion network in 1861 enabling parts of the population […]

Written by healtheconbotwp

The Drive toward Universal Health Coverage: Progress and Challenges around the World

from Health Economics at http://bit.ly/2pjT4BD on April 30, 2017 at 08:26AM To move toward universal health coverage to enable everyone to receive quality health care without financial hardship, three dimensions should be considered simultaneously: population to be covered, health services to be covered, and financial risk protection. Collaboration among ministries of health, finance, education, and […]

Written by healtheconbotwp

Evaluating the Effects of a Targeted Home Visiting Program on Maternal and Child Health Outcomes

from Health Economics at http://bit.ly/2oXUaRc on April 30, 2017 at 08:26AM We evaluate the effects of home visiting targeted towards disadvantaged first-time mothers on maternal and child health outcomes. Our analysis exploits a randomized controlled trial and combines rich longitudinal survey data with unique administrative health data. In a context in which the target group […]

Written by healtheconbotwp

Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics

from PharmacoEconomics at http://bit.ly/2phTRDm on April 29, 2017 at 07:39PM Abstract Background Policies such as the Cancer Drugs Fund in England assumed a societal preference to fund cancer care relative to other conditions, even if that resulted in lower health gain for the population overall. Objective The aim of this study was to investigate the […]

Written by healtheconbotwp

Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview

from PharmacoEconomics at http://bit.ly/2oTZBja on April 29, 2017 at 07:39PM Abstract Decision-analytic models for cost-effectiveness analysis are developed in a variety of software packages where the accuracy of the computer code is seldom verified. Although modeling guidelines recommend using state-of-the-art quality assurance and control methods for software engineering to verify models, the fields of pharmacoeconomics […]

Written by healtheconbotwp

Nature vs Nurture

from THCB at http://bit.ly/2qgBWhz on April 29, 2017 at 11:55AM   By, SAURABH JHA MD My wife chooses sides in the nature-versus-nurture war expeditiously. When our children are polite, she credits her nurture. When they’re rowdy, she blames my genes. But the nature-nurture war won’t be resolved anytime soon. The gene played a significant role […]

Written by healtheconbotwp

The 28th Jerusalem School in Economic Theory: Mechanism Design, June 27 – July 6, 2017

from Market Design at http://bit.ly/2pvy0Zn on April 29, 2017 at 06:48AM The 28th Jerusalem School in Economic Theory Mechanism Design Event date: June 27 – July 6, 2017  Organizers: Eric Maskin, General Director (Harvard University)Elchanan Ben-Porath, Codirector (The Hebrew University)Stephen Morris (Princeton University) Mechanism design is the “reverse engineering” part of economic theory. Normally, economists study […]

Written by healtheconbotwp

Israel transplant investigation

from Market Design at http://bit.ly/2oErmkm on April 28, 2017 at 06:33AM The Israeli organization Matnat Chaim (Gift of Life), founded by Rabbi Yeshayahu Heber, is under investigation about whether it encouraged families to contribute to the organization in order to receive a shorter waiting time for a kidney transplant. Organ donor organization suspected of moving […]

Written by healtheconbotwp

Gender Differences in the Association Between Conduct Disorder and Risky Sexual Behavior

from RAND Research Topic: Health and Health Care at http://bit.ly/2pqW0wQ on April 27, 2017 at 03:14PM Despite suggestions that there are gender differences in the association between conduct disorder (CD) and risky sexual behavior, limited empirical research has examined this question. Youth (N = 616) were recruited from four primary care clinics and completed questions […]

Written by healtheconbotwp

Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib

from PharmacoEconomics – Open at http://bit.ly/2qjZPkB on April 27, 2017 at 01:00PM Abstract Background Ibrutinib was introduced in Japan in 2016 as a new oral treatment option for patients with relapsed/refractory (RR) chronic lymphocytic leukemia (CLL). There is increasing interest from the Japanese government to assess economic aspects of new medical interventions, especially in the […]

Written by healtheconbotwp

How excluding some benefits from value assessment of new drugs impacts innovation

from Health Economics at http://bit.ly/2qbrrcH on April 27, 2017 at 12:40PM Abstract Payers often assess the benefits of new drugs relative to costs for reimbursement purposes, but they frequently exclude some drugs’ option-related benefits, reducing their reimbursement chances, and making them less attractive R&D investments. We develop and test a real options model of R&D […]

Written by healtheconbotwp

Does my high blood pressure improve your survival? Overall and subgroup learning curves in health

from Health Economics at http://bit.ly/2qcGMfD on April 27, 2017 at 12:10PM Summary Learning curves in health are of interest for a wide range of medical disciplines, healthcare providers, and policy makers. In this paper, we distinguish between three types of learning when identifying overall learning curves: economies of scale, learning from cumulative experience, and human […]

Written by healtheconbotwp

Unobserved health care expenditures: How important is censoring in register data?

from Health Economics at http://bit.ly/2oQqLby on April 27, 2017 at 12:10PM Abstract Accurate information on individuals’ health service use is important for evaluating health policies and analyzing health care demand. Although register data are considered to be more reliable than survey data, little is known about the extent and effect of censoring of the expenditure […]

Written by healtheconbotwp

Valuing productivity costs using the friction-cost approach: Estimating friction-period estimates by occupational classifications for the UK

from Health Economics at http://bit.ly/2qcvOGX on April 27, 2017 at 12:10PM Abstract The friction cost approach has been proposed as an alternative to the human capital approach in estimating productivity costs. However, it is difficult, in practice, to apply this approach due to limited availability of context-specific data. Using national and firm-level data on vacancy […]

Written by healtheconbotwp

New amendment to GOP health bill effectively allows full elimination of community rating, exposing sick to higher premiums

from Brookings: Topics – Health at http://brook.gs/2pDqtsz on April 27, 2017 at 11:22AM By Matthew Fiedler In recent weeks, the Trump Administration and House Republicans have been engaged in negotiations aimed at resurrecting the American Health Care Act (AHCA). Last night, the House Rules Committee posted an amendment to the AHCA emerging from those negotiations. […]